The Figure panel 2C (loading control), Supplementary Figure panels S1A (loading control) and S3A (upper panel) reported in Olson et al., 2014 [1] are incorrect. The GADPH loading control in Figure 2C is the mirror image of the ACTIN loading control in Figure 1C of a previous publication [2], and the upper panel of Figure S3A is the same as the upper panel of Figure 1A in the current paper. The GAPDH loading control in Figure S1A is a processed image (2° counter clockwise rotation) from the loading control of a Western blot, from which lanes 3 and 4 correspond to the loading control in Figure 2G in the current paper.
Figure 2. Validation of anti-MeCP2E2 antibody and detection of MeCP2 isoforms in mouse brain.
(A) Schematic representation of MeCP2E1 and MeCP2E2 protein structures, differing only in their N-terminal sequences. MBD: methyl binding domain, ID: intervening domain, TRD: transcriptional repression domain, CTD: C-terminal domain (adapted from [21]). (B) Schematics of MECP2E1 (Retro-EF1α-E1) and MECP2E2 (Retro-EF1α-E2) retroviral vectors with C-MYC tag that were used for transfection of Phoenix cells (in C) and transduction of NIH3T3 cells (in D) (adapted from [18]). (C) Western blot (WB) experiment to detect MeCP2E2 expression in control non-transfected (NT), MECP2E1 transfected (E1-T), MECP2E2 transfected (E2-T), and E2-T pre-incubated with E2 antigenic peptide. Anti-MYC labelling was used as a positive control. (D) MeCP2E2 detection by immunofluorescence staining in transduced NIH3T3 cells with either a) MECP2E1, or b) MECP2E2 retroviral vectors. (E) Detection of endogenous MeCP2E2 by immunohistochemistry in the CA1 region of adult mouse hippocampus from a) wild type (WT) (Mecp2 tm1.1Bird y/+), and b) null (Mecp2 tm1.1Bird y/-) Mecp2 mice. (F) Controls to verify the specificity of anti-MeCP2E2 by IHC in the adult mouse brain; a) primary omission, b) anti-MeCP2E2 incubation with IgY, pre-incubation of the newly generated anti-MeCP2E2 antibody with the antigenic peptide against c) MeCP2E2, d) MeCP2E1, e) C-terminus of MeCP2. (G) Western blot to detect MeCP2E2 in the WT adult mouse brain and Mecp2 null mice. GAPDH was used as a loading control. (H) a) Confocal images of MeCP2E1 in WT adult mouse brain hippocampus CA1 region. b) Signal intensity profile analysis indicates the enrichment of MeCP2E1 at the DAPI-rich heterochromatin regions of nuclei. (I) a) Confocal images of MeCP2E2 in WT adult mouse brain hippocampus CA1 region. b) Signal intensity profile analysis of MeCP2E1 and DAPI co-localization indicating MeCP2E2 detection at the DAPI-rich heterochromatin regions of nuclei. Scale bars represent 20 µm in D-E, 10 µm in D, and 2 µm in H-I.
The authors apologize for these errors, which happened during the assembly of the figures. Please refer to the corrected Figure 2 here, and the corrected Figures S1 and S3 in the Supporting Information section of this correction. The raw data corresponding to each corrected figure panel is also included. These corrections do not affect the results or conclusions reported in the article.
The authors also correct the following statement in the Introduction:
Paragraph 2 on page 2: “Due to the lack of anti-MeCP2E2 antibodies, comparative analysis of both MeCP2 isoforms at the protein levels in any system has not been reported to date.”
While this manuscript was under review, an article was published by Yasui et al. in Human Molecular Genetics, which did report MeCP2E1 and E2 at the protein level in mouse brain [3]. This study was cited as reference 22 but the statement in the Introduction should have been revised to reflect the findings by Yasui et al. In addition, a publication by Kaddoum et al. reported an analysis of expression of the MeCP2 isoforms in mouse brain [4].
The authors would like to revise the statement in the Introduction to read as below:
“Dr. Dag Yasui’s group, in collaboration with our lab, has recently reported the expression of MeCP2E1 and MeCP2E2 in the mouse brain [22]. Kaddoum et al. also reported an expression analysis of the MeCP2 isoforms in mouse brain. However, a comparative transcript and protein correlation analysis of the two Mecp2/MeCP2 isoforms in different brain regions and during mouse brain development has not been reported previously.”
Supporting Information
References
- 1. Olson CO, Zachariah RM, Ezeonwuka CD, Liyanage VRB, Rastegar M (2014) Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements. PLoS ONE 9(3): e90645 10.1371/journal.pone.0090645 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Zachariah RM, Olson CO, Ezeonwuka C, Rastegar M (2012) Novel MeCP2 Isoform-Specific Antibody Reveals the Endogenous MeCP2E1 Expression in Murine Brain, Primary Neurons and Astrocytes. PLoS ONE 7(11): e49763 10.1371/journal.pone.0049763 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yasui DH, Gonzales ML, Aflatooni JO, Crary FK, Hu DJ, et al. (2014) Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet. [DOI] [PMC free article] [PubMed]
- 4. Kaddoum L, Panayotis N, Mazarguil H, Giglia-Mari G, Roux JC, et al. (2013) Isoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain. F1000Res. 2: 204 10.12688/f1000research.2-204.v1 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

